Zkusit zdarma
Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.

NTLA
Cena:
$ 12.60
+0.23 (1.86%)
Valuace
93
Růst
23
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Intellia Therapeutics, Inc. (NTLA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Intellia Therapeutics, Inc. (NTLA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

21:40 12-05-2026

Intellia Therapeutics, Inc. (NTLA) Presents at Bank of America Global Healthcare Conference 2026 Tra...

NTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in Focus

NTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in Focus

12:47 12-05-2026

Intellia cuts its Q1 loss, advances late-stage gene-editing programs and plans a 2027 launch for lon...

Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Misses Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Misses Revenue Estimates

9:41 11-05-2026

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.81 per share versus the Zack...

Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates

Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates

7:30 11-05-2026

Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA sub...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

11:01 07-05-2026

Intellia Therapeutics (NTLA) possesses the right combination of the two key ingredients for a likely...

Intellia Therapeutics to Participate in Upcoming Investor Conferences

Intellia Therapeutics to Participate in Upcoming Investor Conferences

7:30 05-05-2026

CAMBRIDGE, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a lea...

Intellia Therapeutics Posts Phase 3 HAELO Win for lonvo-z, Begins Rolling FDA BLA Filing

Intellia Therapeutics Posts Phase 3 HAELO Win for lonvo-z, Begins Rolling FDA BLA Filing

15:13 29-04-2026

Intellia Therapeutics (NASDAQ: NTLA) highlighted top-line results from its Phase III HAELO trial eva...

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock

7:00 29-04-2026

CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a l...

NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA

NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA

14:06 28-04-2026

Intellia shares drop 4% despite phase III data meeting all endpoints. The company begins a rolling F...

Intellia Announces Proposed Public Offering of Common Stock

Intellia Announces Proposed Public Offering of Common Stock

16:01 27-04-2026

CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a l...

Intellia Therapeutics, Inc. (NTLA) Discusses Topline Phase 3 HAELO Trial Results for Lonvoguran Ziclumeran in Hereditary Angioedema Transcript

Intellia Therapeutics, Inc. (NTLA) Discusses Topline Phase 3 HAELO Trial Results for Lonvoguran Ziclumeran in Hereditary Angioedema Transcript

15:11 27-04-2026

Intellia Therapeutics, Inc. (NTLA) Discusses Topline Phase 3 HAELO Trial Results for Lonvoguran Zicl...

Wall Street on Edge Ahead of Next U.S.-Iran Development

Wall Street on Edge Ahead of Next U.S.-Iran Development

12:05 27-04-2026

Stocks are lower across the board, as investors await the latest U.S.-Iran developments and monitor ...

Intellia Therapeutics FDA Rolling Application For Gene Therapy Puts Hype To Test

Intellia Therapeutics FDA Rolling Application For Gene Therapy Puts Hype To Test

10:07 27-04-2026

Intellia Therapeutics Inc. (NASDAQ:NTLA) shares are up on Monday after the company announced a rolli...

Intellia Therapeutics' rare genetic disorder therapy meets main goal in trial

Intellia Therapeutics' rare genetic disorder therapy meets main goal in trial

7:06 27-04-2026

Intellia ​Therapeutics said ‌on ​Monday ​its experimental ⁠therapy ​for ​a rare ​gen...

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

7:01 27-04-2026

Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition succeeded in a P...

Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema

Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema

7:00 27-04-2026

CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a l...

Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026

Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026

16:05 24-04-2026

World's first Phase 3 readout for an in vivo CRISPR gene editing candidate Company to host webcast t...

Massachusetts Financial Services Co. MA Makes New $318,000 Investment in Intellia Therapeutics, Inc. $NTLA

Massachusetts Financial Services Co. MA Makes New $318,000 Investment in Intellia Therapeutics, Inc. $NTLA

4:26 19-04-2026

Massachusetts Financial Services Co. MA bought a new position in Intellia Therapeutics, Inc. (NASDAQ...

NTLA Stock Rises 20% in 3 Months: Here's What You Should Know

NTLA Stock Rises 20% in 3 Months: Here's What You Should Know

10:36 16-04-2026

Intellia stock climbs nearly 20% in three months as pipeline progress, lifted FDA holds, and late-st...

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?

17:28 08-03-2026

Intellia Therapeutics is getting around a recent major regulatory setback. However, the stock still ...

close

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-02-2026
CAMBRIDGE, MASS., FEB. 06, 2026 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ: NTLA), A LE...
Více zde

INTELLIA THERAPEUTICS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2026
CAMBRIDGE, MASS., JAN. 07, 2026 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-12-2025
CAMBRIDGE, MASS., DEC. 05, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS PRESENTS POSITIVE LONGER-TERM PHASE 1 DATA OF NEXIGURAN ZICLUMERAN (NEX-Z) IN PATIENTS WITH TRANSTHYRETIN (ATTR) AMYLOIDOSIS WITH CARDIOMYOPATHY

10-11-2025
CAMBRIDGE, MASS., NOV. 10, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS PRESENTS POSITIVE POOLED PHASE 1/2 DATA OF LONVOGURAN ZICLUMERAN (LONVO-Z) IN PATIENTS WITH HEREDITARY ANGIOEDEMA

08-11-2025
CAMBRIDGE, MASS., NOV. 08, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ: NTLA), A LE...
Více zde

INTELLIA THERAPEUTICS PROVIDES UPDATE ON MAGNITUDE CLINICAL TRIALS OF NEXIGURAN ZICLUMERAN (NEX-Z)

27-10-2025
CAMBRIDGE, MASS., OCT. 27, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-10-2025
CAMBRIDGE, MASS., OCT. 03, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS ANNOUNCES POSITIVE LONGER-TERM PHASE 1 DATA FOR NEXIGURAN ZICLUMERAN (NEX-Z) IN PATIENTS WITH HEREDITARY TRANSTHYRETIN (ATTR) AMYLOIDOSIS WITH POLYNEUROPATHY

25-09-2025
CAMBRIDGE, MASS., SEPT. 25, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LE...
Více zde

INTELLIA THERAPEUTICS COMPLETES ENROLLMENT IN THE GLOBAL PHASE 3 HAELO STUDY OF LONVOGURAN ZICLUMERAN (LONVO-Z) FOR HEREDITARY ANGIOEDEMA

18-09-2025
CAMBRIDGE, MASS., SEPT. 18, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LE...
Více zde

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

01-08-2025
CAMBRIDGE, MASS., AUG. 01, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA INVESTIGATION ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING INTELLIA THERAPEUTICS, INC. ON BEHALF OF LONG-TERM STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

31-07-2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION ATTORNEYS ENCOURAGE INVESTORS WHO SUFFERED LOSSES IN INTELLIA...
Více zde

INTELLIA THERAPEUTICS TO HOLD CONFERENCE CALL TO DISCUSS SECOND QUARTER 2025 EARNINGS AND COMPANY UPDATES

31-07-2025
CAMBRIDGE, MASS., JULY 31, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

07-07-2025
CAMBRIDGE, MASS., JULY 07, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS ANNOUNCES POSITIVE THREE-YEAR DATA FROM PHASE 1 TRIAL OF LONVOGURAN ZICLUMERAN (LONVO-Z) IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE) AT THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY CONGRESS

15-06-2025
CAMBRIDGE, MASS., JUNE 15, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-06-2025
CAMBRIDGE, MASS., JUNE 05, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEA...
Více zde

INTELLIA ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING INTELLIA THERAPEUTICS, INC. ON BEHALF OF LONG-TERM STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

22-05-2025
NEW YORK, MAY 22, 2025 (GLOBE NEWSWIRE) -- BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED SHAR...
Více zde

INTELLIA ANNOUNCES POSITIVE TWO-YEAR FOLLOW-UP DATA FROM ONGOING PHASE 1 STUDY OF NEXIGURAN ZICLUMERAN (NEX-Z), IN PATIENTS WITH HEREDITARY TRANSTHYRETIN (ATTR) AMYLOIDOSIS WITH POLYNEUROPATHY AT PERIPHERAL NERVE SOCIETY ANNUAL MEETING

18-05-2025
CAMBRIDGE, MASS., MAY 18, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEAD...
Více zde

INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-05-2025
CAMBRIDGE, MASS., MAY 06, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEAD...
Více zde

INTELLIA THERAPEUTICS TO HOLD CONFERENCE CALL TO DISCUSS FIRST QUARTER 2025 EARNINGS AND COMPANY UPDATES

01-05-2025
CAMBRIDGE, MASS., MAY 01, 2025 (GLOBE NEWSWIRE) -- INTELLIA THERAPEUTICS, INC. (NASDAQ:NTLA), A LEAD...
Více zde

LAWSUIT FOR INVESTORS IN SHARES OF INTELLIA THERAPEUTICS, INC. (NASDAQ: NTLA) ANNOUNCED BY THE SHAREHOLDERS FOUNDATION

23-04-2025
SAN DIEGO , APRIL 23, 2025 /PRNEWSWIRE/ -- SHAREHOLDERS FOUNDATION, INC. ANNOUNCES THAT A LAWSUIT IS...
Více zde

SHAREHOLDERS OF INTELLIA THERAPEUTICS, INC. SHOULD CONTACT LEVI & KORSINSKY BEFORE APRIL 14, 2025 TO DISCUSS YOUR RIGHTS - NTLA

14-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 14, 2025 / IF YOU SUFFERED A LOSS ON YOUR INTELLIA THERAPEUTI...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM REMINDS INVESTORS WITH LOSSES ON THEIR INVESTMENT IN INTELLIA THERAPEUTICS, INC. OF CLASS ACTION LAWSUIT AND UPCOMING DEADLINES - NTLA

14-04-2025
NEW YORK , APRIL 14, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BE...
Více zde

NTLA INVESTOR ALERT: BRONSTEIN, GEWIRTZ & GROSSMAN LLC ANNOUNCES THAT INTELLIA THERAPEUTICS, INC. INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD CLASS ACTION LAWSUIT

14-04-2025
NEW YORK, APRIL 14, 2025 (GLOBE NEWSWIRE) -- ATTORNEY ADVERTISING -- BRONSTEIN, GEWIRTZ & GROSSMAN, ...
Více zde

LEVI & KORSINSKY REMINDS SHAREHOLDERS OF A LEAD PLAINTIFF DEADLINE OF APRIL 14, 2025 IN INTELLIA LAWSUIT - NTLA

14-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 14, 2025 / IF YOU SUFFERED A LOSS ON YOUR INTELLIA THERAPEUTI...
Více zde

NTLA DEADLINE: ROSEN, A LEADING AND RANKED FIRM, ENCOURAGES INTELLIA THERAPEUTICS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT APRIL 14 DEADLINE IN SECURITIES CLASS ACTION - NTLA

14-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 14, 2025 / WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW ...
Více zde

NTLA INVESTORS HAVE OPPORTUNITY TO LEAD INTELLIA THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM

14-04-2025
LOS ANGELES--(BUSINESS WIRE)--NTLA INVESTORS HAVE OPPORTUNITY TO LEAD INTELLIA THERAPEUTICS, INC. SE...
Více zde

LEVI & KORSINSKY ANNOUNCES THE FILING OF A SECURITIES CLASS ACTION ON BEHALF OF INTELLIA THERAPEUTICS, INC. (NTLA) SHAREHOLDERS

14-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 14, 2025 / IF YOU SUFFERED A LOSS ON YOUR INTELLIA THERAPEUTI...
Více zde

FINAL DEADLINE TODAY FOR THE INTELLIA THERAPEUTICS, INC. SECURITIES LAWSUIT - CONTACT THE DJS LAW GROUP TO DISCUSS YOUR RIGHTS - NTLA

14-04-2025
LOS ANGELES , APRIL 14, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION ...
Více zde

CLASS ACTION FILED AGAINST INTELLIA THERAPEUTICS, INC. (NTLA) - APRIL 14, 2025 DEADLINE TO JOIN - CONTACT LEVI & KORSINSKY

14-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 14, 2025 / IF YOU SUFFERED A LOSS ON YOUR INTELLIA THERAPEUTI...
Více zde

NTLA INVESTORS ARE REMINDED OF THE FINAL OPPORTUNITY TO LEAD INTELLIA THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM

14-04-2025
LOS ANGELES , APRIL 14, 2025 /PRNEWSWIRE/ --  THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-27 00:00:008-KStáhnout
2026-01-09 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-10-29 00:00:008-KStáhnout
2025-10-27 00:00:008-KStáhnout
2025-09-25 01:00:008-KStáhnout
2025-09-25 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-16 01:00:008-KStáhnout
2025-06-16 00:00:008-KStáhnout
2025-06-12 01:00:008-KStáhnout
2025-06-12 00:00:008-KStáhnout
2025-05-28 01:00:008-KStáhnout
2025-05-28 00:00:008-KStáhnout
2025-05-19 01:00:008-KStáhnout
2025-05-19 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-04-07 01:00:008-KStáhnout
2025-04-07 00:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-02-21 00:00:008-KStáhnout
2025-02-20 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-11-18 00:00:008-KStáhnout
2024-11-17 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-10-25 01:00:008-KStáhnout
2024-10-25 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-26 01:00:008-KStáhnout
2024-06-26 00:00:008-KStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-04-15 01:00:008-KStáhnout
2024-04-15 00:00:008-KStáhnout
2024-03-22 00:00:008-KStáhnout
2024-03-21 23:00:008-KStáhnout
2024-02-23 00:00:008-KStáhnout
2024-02-22 23:00:008-KStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-22 00:00:0010-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-02-21 23:00:0010-KStáhnout
2024-02-01 00:00:008-KStáhnout
2024-01-31 23:00:008-KStáhnout
2024-01-04 00:00:008-KStáhnout
2024-01-03 23:00:008-KStáhnout
2023-12-06 00:00:008-KStáhnout
2023-12-05 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-01 23:00:008-KStáhnout
2023-10-18 01:00:008-KStáhnout
2023-10-18 00:00:008-KStáhnout
2023-10-03 01:00:008-KStáhnout
2023-10-03 00:00:008-KStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 01:00:0010-QStáhnout
2023-08-03 00:00:008-KStáhnout
2023-08-03 00:00:0010-QStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-06-12 01:00:008-KStáhnout
2023-06-12 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-04-17 01:00:008-KStáhnout
2023-04-17 00:00:008-KStáhnout
2023-03-24 00:00:008-KStáhnout
2023-03-23 23:00:008-KStáhnout
2023-03-02 00:00:008-KStáhnout
2023-03-01 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-23 00:00:0010-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-02-22 23:00:0010-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-12-01 00:00:008-KStáhnout
2022-11-30 23:00:008-KStáhnout
2022-11-14 00:00:008-KStáhnout
2022-11-13 23:00:008-KStáhnout
2022-11-07 00:00:008-KStáhnout
2022-11-06 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-09-16 01:00:008-KStáhnout
2022-09-16 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-24 01:00:008-KStáhnout
2022-06-24 00:00:008-KStáhnout
2022-06-15 01:00:008-KStáhnout
2022-06-15 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-05-03 01:00:008-KStáhnout
2022-05-03 00:00:008-KStáhnout
2022-03-04 00:00:008-KStáhnout
2022-03-03 23:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-02-03 00:00:008-KStáhnout
2022-02-02 23:00:008-KStáhnout
2022-01-06 00:00:008-KStáhnout
2022-01-05 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-07-02 01:00:008-KStáhnout
2021-07-02 00:00:008-KStáhnout
2021-06-28 01:00:008-KStáhnout
2021-06-28 00:00:008-KStáhnout
2021-06-24 01:00:008-KStáhnout
2021-06-24 00:00:008-KStáhnout
2021-06-22 01:00:008-KStáhnout
2021-06-22 00:00:008-KStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-04-12 01:00:008-KStáhnout
2021-04-12 00:00:008-KStáhnout
2021-02-26 00:00:0010-KStáhnout
2021-02-25 23:00:0010-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-01-07 00:00:008-KStáhnout
2021-01-06 23:00:008-KStáhnout
2020-12-02 00:00:008-KStáhnout
2020-12-01 23:00:008-KStáhnout
2020-11-09 00:00:008-KStáhnout
2020-11-08 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-10-19 01:00:008-KStáhnout
2020-10-19 00:00:008-KStáhnout
2020-10-05 01:00:008-KStáhnout
2020-10-05 00:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-06-19 01:00:008-KStáhnout
2020-06-19 00:00:008-KStáhnout
2020-06-03 01:00:008-KStáhnout
2020-06-03 00:00:008-KStáhnout
2020-06-01 01:00:008-KStáhnout
2020-06-01 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-04-09 01:00:008-KStáhnout
2020-04-09 00:00:008-KStáhnout
2020-03-26 00:00:008-KStáhnout
2020-03-25 23:00:008-KStáhnout
2020-03-13 00:00:008-KStáhnout
2020-03-12 23:00:008-KStáhnout
2020-02-27 00:00:008-KStáhnout
2020-02-27 00:00:0010-KStáhnout
2020-02-26 23:00:008-KStáhnout
2020-02-26 23:00:0010-KStáhnout
2020-01-09 00:00:008-KStáhnout
2020-01-08 23:00:008-KStáhnout
2019-12-16 00:00:008-KStáhnout
2019-12-15 23:00:008-KStáhnout
2019-10-31 00:00:008-KStáhnout
2019-10-31 00:00:0010-QStáhnout
2019-10-30 23:00:008-KStáhnout
2019-10-30 23:00:0010-QStáhnout
2019-09-26 01:00:008-KStáhnout
2019-09-26 00:00:008-KStáhnout
2019-08-01 01:00:008-KStáhnout
2019-08-01 01:00:0010-QStáhnout
2019-08-01 00:00:008-KStáhnout
2019-08-01 00:00:0010-QStáhnout
2019-05-22 01:00:008-KStáhnout
2019-05-22 00:00:008-KStáhnout
2019-05-02 01:00:008-KStáhnout
2019-05-02 01:00:0010-QStáhnout
2019-05-02 00:00:008-KStáhnout
2019-05-02 00:00:0010-QStáhnout
2019-04-05 01:00:008-KStáhnout
2019-04-05 00:00:008-KStáhnout
2019-02-27 00:00:008-KStáhnout
2019-02-27 00:00:0010-KStáhnout
2019-02-26 23:00:008-KStáhnout
2019-02-26 23:00:0010-KStáhnout
2019-01-24 00:00:008-KStáhnout
2019-01-23 23:00:008-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-12-06 00:00:008-KStáhnout
2018-12-05 23:00:008-KStáhnout
2018-10-31 00:00:008-KStáhnout
2018-10-31 00:00:0010-QStáhnout
2018-10-30 23:00:008-KStáhnout
2018-10-30 23:00:0010-QStáhnout
2018-10-29 00:00:008-KStáhnout
2018-10-28 23:00:008-KStáhnout
2018-08-01 01:00:008-KStáhnout
2018-08-01 01:00:0010-QStáhnout
2018-08-01 00:00:008-KStáhnout
2018-08-01 00:00:0010-QStáhnout
2018-07-20 01:00:008-KStáhnout
2018-07-20 00:00:008-KStáhnout
2018-06-22 01:00:008-KStáhnout
2018-06-22 00:00:008-KStáhnout
2018-05-21 01:00:008-KStáhnout
2018-05-21 00:00:008-KStáhnout
2018-05-01 01:00:008-KStáhnout
2018-05-01 01:00:0010-QStáhnout
2018-05-01 00:00:008-KStáhnout
2018-05-01 00:00:0010-QStáhnout
2018-04-17 01:00:008-KStáhnout
2018-04-17 00:00:008-KStáhnout
2018-03-14 00:00:008-KStáhnout
2018-03-14 00:00:0010-KStáhnout
2018-03-13 23:00:008-KStáhnout
2018-03-13 23:00:0010-KStáhnout
2017-12-18 00:00:008-KStáhnout
2017-12-17 23:00:008-KStáhnout
2017-11-03 00:00:008-KStáhnout
2017-11-02 23:00:008-KStáhnout
2017-10-31 00:00:008-KStáhnout
2017-10-31 00:00:0010-QStáhnout
2017-10-30 23:00:008-KStáhnout
2017-10-30 23:00:0010-QStáhnout
2017-09-01 01:00:008-KStáhnout
2017-09-01 00:00:008-KStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 00:00:008-KStáhnout
2017-08-01 01:00:008-KStáhnout
2017-08-01 01:00:0010-QStáhnout
2017-08-01 00:00:008-KStáhnout
2017-08-01 00:00:0010-QStáhnout
2017-07-25 01:00:008-KStáhnout
2017-07-25 00:00:008-KStáhnout
2017-05-18 01:00:008-KStáhnout
2017-05-18 00:00:008-KStáhnout
2017-05-02 01:00:008-KStáhnout
2017-05-02 01:00:0010-QStáhnout
2017-05-02 00:00:008-KStáhnout
2017-05-02 00:00:0010-QStáhnout
2017-04-13 01:00:008-KStáhnout
2017-04-13 00:00:008-KStáhnout
2017-03-14 00:00:008-KStáhnout
2017-03-14 00:00:0010-KStáhnout
2017-03-13 23:00:008-KStáhnout
2017-03-13 23:00:0010-KStáhnout
2017-02-15 00:00:008-KStáhnout
2017-02-14 23:00:008-KStáhnout
2016-12-16 00:00:008-KStáhnout
2016-12-15 23:00:008-KStáhnout
2016-12-13 00:00:008-KStáhnout
2016-12-12 23:00:008-KStáhnout
2016-11-04 00:00:008-KStáhnout
2016-11-03 23:00:008-KStáhnout
2016-11-01 00:00:008-KStáhnout
2016-11-01 00:00:0010-QStáhnout
2016-10-31 23:00:008-KStáhnout
2016-10-31 23:00:0010-QStáhnout
2016-08-04 01:00:008-KStáhnout
2016-08-04 01:00:0010-QStáhnout
2016-08-04 00:00:008-KStáhnout
2016-08-04 00:00:0010-QStáhnout
2016-06-03 01:00:0010-QStáhnout
2016-06-03 00:00:0010-QStáhnout
2016-05-17 01:00:008-KStáhnout
2016-05-17 00:00:008-KStáhnout
preloader